February 27, 2023
February 27, 2023
Categories

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

Do you like it?
Read more
February 23, 2023
February 23, 2023
Categories

A focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma

Do you like it?
Read more
February 15, 2023
February 15, 2023
Categories

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

Do you like it?
Read more
February 15, 2023
February 15, 2023
Categories

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

The January/February 2023 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

Do you like it?
Read more
February 9, 2023
February 9, 2023
Categories

The application period is now open for Spring Meeting Attendance Awards for minority trainees

Do you like it?
Read more
February 6, 2023
February 6, 2023
Categories

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

Do you like it?
Read more
February 1, 2023
February 1, 2023
Categories

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

Do you like it?
Read more
ECOG-ACRIN Cancer Research Group